Drug
Z 1018
Z 1018: highest development phase Phase 1/2, developed by Dynavax Technologies. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Dynavax Technologies
Trials
| Drug | Phase | Indication |
|---|---|---|
| Z-1018 NCT06569823 | Phase 1/2 | Shingles |
| Z-1018 NCT05245838 | Phase 1 | Shingles |
Latest
No recent events.
Follow Z 1018 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.